Conference Paper
RDF
pages:
-
1364 DIAGNOSING HEPATOTOXICITY ATTRIBUTABLE TO HERBAL & DIETARY SUPPLEMENTS (HDS): TEST-RETEST RELIABILITY OF A NOVEL CAUSALITY ASSESSMENT TOOL
-
1364: Long Term Potassium Citrate Therapy does Impact Urine pH
-
1366: Correlation between Stone Formation and Weight Loss After Roux-en-Y Gastric Bypass
-
137: Can the gestation-adjusted projection (GAP) method be used in obese to super morbidly obese women to predict birth weight?
-
1385: Significant Variation in BPH-Surgical Rates Explained by Medical Therapy Rates, Health Resources and Sociodemograpidc Factors
-
1386. Reduction in Expected Survival Associated with Nontuberculous Mycobacterial Pulmonary Infection
-
138: Neurocognitive Evaluation of Destination Therapy Pateints Receiving Continuous Flow Left Ventricular Assist Devices
-
138: Prediction of birth weight by early versus late third trimester ultrasound in morbidly obese women
-
139. Methlyome-Wide Changes Associated With Childhood Trauma and its Long-Term Outcomes
-
1395 Unique transcriptional signature primes oral mucosa for rapid wound healing in humans
-
13: Inhibition of toll-like receptors and inflammatory response in primary chorion cells
-
14-bit, 2.2MS/s sigma delta ADCs
-
14. Next Generation AAV Vectors for Limiting Systemic Leakage and Improving Safety Following CNS Administration
-
14.3 Leveraging Technology to Support Training, Treatment Adherence, and Outcomes
-
140-LB: NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects
-
1401 Activation of nociceptive fibers following acute skin injury triggers innate antiviral immunity
-
1403: “Insignificant” Prostate Cancer Treated by Radical Retropubic Prostatectomy has a Risk of Progression Similar to Low-Risk “Significant” Cancer
-
140: The maximal oxytocin infusion rate in labor is associated with uterine atony
-
141 STAGE MIGRATION IN PROSTATE CANCER AT RADICAL PROSTATECTOMY DURING THE PSA ERA IS ASSOCIATED WITH RELATIVELY CONSTANT GLEASON SCORE
-
1411 POSTER Endpoints for Validation of Tumour Markers for Recurrence Risk -Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581
-
1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men?
-
141: Infection during Mechanical Circulatory Support: Can We Really Expect a Better Outlook with Continuous Flow Technology
-
142 HIV Frequently Elicits Mucosal and Plasma Env-Specific IgA With a Rapid Initial Decline In Acute Infection
-
1423: The Impact of Gleason Score on the Predictive Value of PSA Doubling Time
-
142 Intradiscal Injection of Simvastatin Results in Radiologic, Histologic, and Genetic Evidence of Disc Regeneration in a Rat Model of Degenerative Disc Disease
-
1434TiP MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress
-
1437 EPIDEMIOLOGY AND VARIATION IN MANAGEMENT OF IATROGENIC BLOODSTREAM INFECTIONS FOLLOWING TRANSRECTAL PROSTATE BIOPSY PROCEDURES
-
1437 LOW-CARBOHYDRATE DIETS AND PROSTATE CANCER GROWTH: HOW LOW IS “LOW ENOUGH”?
-
1437TiP Phase Ib/II, open label, dose escalation and expansion trial of tucatinib in combination with trastuzumab and oxaliplatin-based chemotherapy in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in Progress)
-
144 SYNERGISTIC ROLES OF HEPATIC ENCEPHALOPATHY AND OBSTRUCTIVE SLEEP APNEA IN DISTURBANCE OF SLEEP ARCHITECTURE IN PATIENTS WITH CIRRHOSIS
pages: